European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Gynecologic sarcoma: a clinico-pathological review
1 Department of Obstetrics, Gynecology, and Urology, Sapienza University of Rome, Sant’Andrea Hospital, Rome (Italy)
Eur. J. Gynaecol. Oncol. 2013, 34(5), 379–386;
Published: 10 October 2013
Most of the cases showing good prognosis in literature are probably intermediate tumors between benign and malignant of undetermined malignant potential (UMP) and other tumors with intermediate features which are currently not considered among sarcomas. Misdiagnosis of a malignant lesion as a benign one has a tragic outcome for the patient. Best therapic choice for sarcomas remains surgery, while chemotherapy (CTX) and radiation therapy (RT) could be used in adjuvant settings. A major effort should be played in the understanding of biological features and behavior of the disease to address a better clinical practice. Uterine sarcomas are rare gynecological tumors; their incidence has been increasing during the last few years.
Endometrial Stromal Sarcoma
Malignant MixedMullerian Tumors